Endocrine response and resistance in bre
β
Julia M.W. Gee; Peter C. Willsher; Frances S. Kenny; John F.R. Robertson; Sarah
π
Article
π
1999
π
John Wiley and Sons
π
French
β 109 KB
π 2 views
We have previously demonstrated that elevated Fos expression may be important in de novo endocrine resistance in breast cancer. However, changes in Fos expression during endocrine response and subsequently on acquisition of resistance are unknown. This study immunocytochemically monitors Fos protein